BiochemistryAdvanced SciencePeer-reviewed
TSHR-targeting nucleic acid aptamer treats Graves' ophthalmopathy via novel allosteric inhibition
Yanchen Zhang, Ende Wu, Weibin Liu…·Wencan Wu
This study develops YC3, a TSHR-targeting aptamer that inhibits TSHR signaling and treats Graves' ophthalmopathy by binding to a novel allosteric site.
1 citation